Thoracic Surgery in Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutant After Tyrosine Kinase Inhibitor Therapy

被引：0
|
作者：
Hsiao, C. [1 ]
Kuo, S. [2 ,3 ]
Chen, K. [4 ]
Chen, J. [2 ,3 ]
机构：
[1] Cheng Hsin Gen Hosp, Surg, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Surg, Taipei, Taiwan
[3] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Dept Surg, Taipei, Taiwan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
Tyrosine kinase inhibitors; Thoracic Surgery; non-small cell lung cancer;
D O I：
10.1016/j.jtho.2018.08.592
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-36
引用
收藏
页码：S474 / S474
页数：1
相关论文
共 50 条
  • [1] Surgery for advanced non-small cell lung cancer patient after epidermal growth factor receptor tyrosine kinase inhibitor neoadjuvant therapy
    Ning, Ye
    Bao, Minwei
    Yan, Xiaoxia
    Xie, Dong
    Jiang, Gening
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (20)
  • [2] Addressing epidermal growth factor receptor tyrosine kinase inhibitor resistance in non-small cell lung cancer
    Noda, Shoko
    Kanda, Shintaro
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (05) : 547 - 556
  • [3] Combined therapy with epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Iwama, Eiji
    Nakanishi, Yoichi
    Okamoto, Isamu
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (03) : 267 - 276
  • [4] Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer
    Asami, Kazuhiro
    Atagi, Shinji
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2014, 5 (04): : 646 - 659
  • [5] Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
    Tan, Chee-Seng
    Cho, Byoung-Chul
    Soo, Ross A.
    LUNG CANCER, 2016, 93 : 59 - 68
  • [6] Treatment of Non-small Cell Lung Carcinoma after Failure of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor
    Lee, Jae Cheol
    Jang, Seung Hun
    Lee, Kye Young
    Kim, Young-Chul
    CANCER RESEARCH AND TREATMENT, 2013, 45 (02): : 79 - 85
  • [7] Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy
    Bunn, Paul A., Jr.
    Dziadziuszko, Rafal
    Varella-Garcia, Marileila
    Franklin, WilburA.
    Witta, Samir E.
    Kelly, Karen
    Hirsch, Fred R.
    CLINICAL CANCER RESEARCH, 2006, 12 (12) : 3652 - 3656
  • [8] PET probe detecting non-small cell lung cancer susceptible to epidermal growth factor receptor tyrosine kinase inhibitor therapy
    Makino, Akira
    Miyazaki, Anna
    Tomoike, Ayaka
    Kimura, Hiroyuki
    Arimitsu, Kenji
    Hirata, Masahiko
    Ohmomo, Yoshiro
    Nishii, Ryuichi
    Okazawa, Hidehiko
    Kiyono, Yasushi
    Ono, Masahiro
    Saji, Hideo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2018, 26 (08) : 1609 - 1613
  • [9] THE ROLE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
    Mok, Tony
    ANNALS OF ONCOLOGY, 2010, 21 : 5 - 5
  • [10] Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer
    Martin-Fernandez, Marisa L.
    CANCERS, 2022, 14 (03)
12345